Discuss politics - join our community by registering for free here! HOP - the political discussion forum

Reply to thread

Message

Re: FDA Rules Against Avastin,, G.O.P should use this as political weapon against Oba

First, let me say that I am very sorry your wife is going through such a difficult time. I know how frightening breast cancer can be, and how difficult on the whole family the stress and fear can be. I am a breast cancer survivor myself.

I would recommend, however, that before you push the panic button, you do some additional research on what that FDA decision would really consist of. It appears (see following link) that this injection would only be disaproved for a very specific treatment of a very specific form of breast cancer, not for all types. So, first of all, it may help you and your wife to find out if your wife's situation would fall under that restriction. I hope not, if it seems to help her.

It seems, however, that this injection has very dangerous consequences also. But, it is clear that, when facing a potentially terminal illness, one is willing to take a lot more risk to be treated than for a casual illness. So I understand your concern.

Here is the link (press release directly from Roche):

Wednesday, Jun 29, 2011

Genentech Provides Update from FDA Hearing on Avastin for Metastatic Breast Cancer

-- FDA Commissioner to Make Final Decision at a Later Date --

Silver Spring, Md. -- June 29, 2011 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that, during a U.S. Food and Drug Administration (FDA) hearing, the FDA's Oncologic Drugs Advisory Committee (ODAC) recommended that the FDA withdraw its approval of Avastin® (bevacizumab) in combination with paclitaxel chemotherapy for previously untreated (first-line) HER2-negative metastatic breast cancer. The committee's recommendation is not the final decision and Avastin plus paclitaxel is still FDA approved for women with HER2-negative metastatic breast cancer. The FDA Commissioner will make the final decision on whether Avastin should remain approved for metastatic breast cancer. The FDA has not announced when the Commissioner will make the final decision.

<blockquote data-quote="Openmind" data-source="post: 163280" data-attributes="member: 3480">Re: FDA Rules Against Avastin,, G.O.P should use this as political weapon against ObaFirst, let me say that I am very sorry your wife is going through such a difficult time.&nbsp; I know how frightening breast cancer can be, and how difficult on the whole family the stress and fear can be.&nbsp; I am a breast cancer survivor myself.I would recommend, however, that before you push the panic button, you do some additional research on what that FDA decision would really consist of.&nbsp; It appears (see following link) that this injection would only be disaproved for a very specific treatment of a very specific form of breast cancer, not for all types.&nbsp; So, first of all, it may help you and your wife to find out if your wife&#039;s situation would fall under that restriction.&nbsp; I hope not, if it seems to help her.It seems, however, that this injection has very dangerous consequences also.&nbsp; But, it is clear that, when facing a potentially terminal illness, one is willing to take a lot more risk to be treated than for a casual illness.&nbsp; So I understand your concern.Here is the link (press release directly from Roche):Wednesday, Jun 29, 2011&nbsp;Genentech Provides Update from FDA Hearing on Avastin for Metastatic Breast Cancer&nbsp;-- FDA Commissioner to Make Final Decision at a Later Date --&nbsp;Silver Spring, Md. --&nbsp; June 29, 2011 --&nbsp; Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that, during a U.S. Food and Drug Administration (FDA) hearing, the FDA&#039;s Oncologic Drugs Advisory Committee (ODAC) recommended that the FDA withdraw its approval of Avastin® (bevacizumab) in combination with paclitaxel chemotherapy for previously untreated (first-line) HER2-negative metastatic breast cancer. The committee&#039;s recommendation is not the final decision and Avastin plus paclitaxel is still FDA approved for women with HER2-negative metastatic breast cancer. The FDA Commissioner will make the final decision on whether Avastin should remain approved for metastatic breast cancer. The FDA has not announced when the Commissioner will make the final decision.</blockquote>

[QUOTE="Openmind, post: 163280, member: 3480"] [b]Re: FDA Rules Against Avastin,, G.O.P should use this as political weapon against Oba[/b] First, let me say that I am very sorry your wife is going through such a difficult time. I know how frightening breast cancer can be, and how difficult on the whole family the stress and fear can be. I am a breast cancer survivor myself. I would recommend, however, that before you push the panic button, you do some additional research on what that FDA decision would really consist of. It appears (see following link) that this injection would only be disaproved for a very specific treatment of a very specific form of breast cancer, not for all types. So, first of all, it may help you and your wife to find out if your wife's situation would fall under that restriction. I hope not, if it seems to help her. It seems, however, that this injection has very dangerous consequences also. But, it is clear that, when facing a potentially terminal illness, one is willing to take a lot more risk to be treated than for a casual illness. So I understand your concern. Here is the link (press release directly from Roche): Wednesday, Jun 29, 2011 Genentech Provides Update from FDA Hearing on Avastin for Metastatic Breast Cancer -- FDA Commissioner to Make Final Decision at a Later Date -- Silver Spring, Md. -- June 29, 2011 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that, during a U.S. Food and Drug Administration (FDA) hearing, the FDA's Oncologic Drugs Advisory Committee (ODAC) recommended that the FDA withdraw its approval of Avastin® (bevacizumab) in combination with paclitaxel chemotherapy for previously untreated (first-line) HER2-negative metastatic breast cancer. The committee's recommendation is not the final decision and Avastin plus paclitaxel is still FDA approved for women with HER2-negative metastatic breast cancer. The FDA Commissioner will make the final decision on whether Avastin should remain approved for metastatic breast cancer. The FDA has not announced when the Commissioner will make the final decision. [/QUOTE]

Verification